![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Cancer risk among HIV-infected people in the U.S. during the modern treatment era
|
|
|
Reported by Jules Levin
CROI 2017 Seattle, WA
Raul U. Hernandez-Ramirez, MS, MPhil1,2*; Meredith S. Shiels, PhD, MHS1; Robert Dubrow, MD, PhD2; Eric A. Engels, MD, MPH1
1Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD;
2Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale School of Medicine, New Haven, CT; *raul.hernandezramirez@yale.edu
![CROI1](../images/030617/030617-10/CROI1.gif)
![CROI2](../images/030617/030617-10/CROI2.gif)
![CROI3](../images/030617/030617-10/CROI3.gif)
![CROI4](../images/030617/030617-10/CROI4.gif)
![CROI5](../images/030617/030617-10/CROI5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|